The report offers detailed coverage of Injectable Anticoagulants industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Injectable Anticoagulants by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.
Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
The report forecast global Injectable Anticoagulants market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Injectable Anticoagulants market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
At the same time, we classify Injectable Anticoagulants according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Market by Application
VTE
ACS/MI
AF
Other
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Injectable Anticoagulants market for the forecast period 2021 - 2025?
• What are the driving forces in the Injectable Anticoagulants market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Injectable Anticoagulants industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?